Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Nguyen

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Plos Pathogens|April 12, 2016
Targeted Isolation of Antibodies Directed against Major Sites of SIV Env VulnerabilityRosemarie D Mason, Hugh C Welles, Cameron Adams, et al.
Plos Pathogens|May 25, 2016
Correction: Targeted Isolation of Antibodies Directed against Major Sites of SIV Env VulnerabilityRosemarie D Mason, Hugh C Welles, Cameron Adams, et al.
Science Translational Medicine|January 18, 2023
The c-Abl inhibitor IkT-148009 suppresses neurodegeneration in mouse models of heritable and sporadic Parkinson's diseaseSenthilkumar S Karuppagounder, Hu Wang, Terence Kelly, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
Systemic in utero gene editing as a treatment for cystic fibrosisAdele S Ricciardi, Christina Barone, Rachael Putman, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2025
Systemic in utero gene editing as a treatment for cystic fibrosisAdele S Ricciardi, Christina Barone, Rachael Putman, et al.
Cell Reports|January 10, 2025
Isolation and structure of broad SIV-neutralizing antibodies reveal a proximal helical MPER epitope recognized by a rhesus multi-donor classJason Gorman, Renguang Du, Yen-Ting Lai, et al.
Geroscience|June 20, 2024
Improved resilience and proteostasis mediate longevity upon DAF-2 degradation in old ageAdrian Molière, Ji Young Cecilia Park, Anita Goyala, et al.
Immunity|October 7, 2019
Isolation and Structure of an Antibody that Fully Neutralizes Isolate SIVmac239 Reveals Functional Similarity of SIV and HIV Glycan ShieldsJason Gorman, Rosemarie D Mason, Leonard Nettey, et al.
Vaccines|January 26, 2021
Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing ResponsesYongping Yang, Wei Shi, Olubukola M Abiona, et al.
Plos Pathogens|June 16, 2022
Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4Hugh C Welles, Hannah A D King, Leonard Nettey, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Plos Pathogens|April 12, 2016
Targeted Isolation of Antibodies Directed against Major Sites of SIV Env VulnerabilityRosemarie D Mason, Hugh C Welles, Cameron Adams, et al.
Plos Pathogens|May 25, 2016
Correction: Targeted Isolation of Antibodies Directed against Major Sites of SIV Env VulnerabilityRosemarie D Mason, Hugh C Welles, Cameron Adams, et al.
Science Translational Medicine|January 18, 2023
The c-Abl inhibitor IkT-148009 suppresses neurodegeneration in mouse models of heritable and sporadic Parkinson's diseaseSenthilkumar S Karuppagounder, Hu Wang, Terence Kelly, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
Systemic in utero gene editing as a treatment for cystic fibrosisAdele S Ricciardi, Christina Barone, Rachael Putman, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2025
Systemic in utero gene editing as a treatment for cystic fibrosisAdele S Ricciardi, Christina Barone, Rachael Putman, et al.
Cell Reports|January 10, 2025
Isolation and structure of broad SIV-neutralizing antibodies reveal a proximal helical MPER epitope recognized by a rhesus multi-donor classJason Gorman, Renguang Du, Yen-Ting Lai, et al.
Geroscience|June 20, 2024
Improved resilience and proteostasis mediate longevity upon DAF-2 degradation in old ageAdrian Molière, Ji Young Cecilia Park, Anita Goyala, et al.
Immunity|October 7, 2019
Isolation and Structure of an Antibody that Fully Neutralizes Isolate SIVmac239 Reveals Functional Similarity of SIV and HIV Glycan ShieldsJason Gorman, Rosemarie D Mason, Leonard Nettey, et al.
Vaccines|January 26, 2021
Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing ResponsesYongping Yang, Wei Shi, Olubukola M Abiona, et al.
Plos Pathogens|June 16, 2022
Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4Hugh C Welles, Hannah A D King, Leonard Nettey, et al.
Pageof 4